Collection
Biosimilars: Opinions, Reviews and Systematic Reviews
- Submission status
- Open
- Open for submission from
- 04 May 2021
- Submission deadline
- Ongoing
A collection of recent opinions, reviews and systematic reviews on biosimilars
Articles (37 in this collection)
-
-
Use of Biosimilars: A Systematic Review of Published Position Statements and Recommendations from Health Organisations and Societies
Authors
- Noraisyah Mohd Sani
- Zoriah Aziz
- Adeeba Kamarulzaman
- Content type: Systematic Review
- Published: 12 March 2024
- Pages: 405 - 423
-
Can Endangered Biosimilar Markets be Rescued? The Need to Bridge Competing Interests for Long-Term Gain
Authors (first, second and last of 5)
- Teresa Barcina Lacosta
- Arnold G. Vulto
- Steven Simoens
- Content type: Commentary
- Published: 26 February 2024
- Pages: 325 - 329
-
Patients’ Perceptions of Biosimilars: A Systematic Review
Authors (first, second and last of 5)
- Qiyou Wu
- Zhitao Wang
- Jing Sun
- Content type: Systematic Review
- Published: 07 September 2023
- Pages: 829 - 841
-
Future Evolution of Biosimilar Development by Application of Current Science and Available Evidence: The Developer’s Perspective
Authors (first, second and last of 4)
- Hillel P. Cohen
- Matthew Turner
- Gillian R. Woollett
- Content type: Current Opinion
- Open Access
- Published: 05 August 2023
- Pages: 583 - 593
-
Historical Overview of Regulatory Approvals and PMDA Assessments for Biosimilar Products in Japan During 2009–2022
Authors (first, second and last of 5)
- Ryosuke Kuribayashi
- Ayuki Nakano
- Futaba Honda
- Content type: Leading Article
- Published: 25 May 2023
- Pages: 443 - 451
-
Comparative Safety Profiles of Oncology Biosimilars: A Systematic Review and Network Meta-analysis
Authors (first, second and last of 6)
- HyeJung Na
- Sun-Hong Kwon
- Eui-Kyung Lee
- Content type: Systematic Review
- Published: 02 February 2023
- Pages: 205 - 218
-
Copies of Biological Medicines: Similar But Not the Same?
Authors
- Pekka Kurki
- Content type: Commentary
- Open Access
- Published: 30 January 2023
- Pages: 123 - 126
-
Switching from One Biosimilar to Another Biosimilar of the Same Reference Biologic: A Systematic Review of Studies
Authors (first, second and last of 6)
- Hillel P. Cohen
- Sohaib Hachaichi
- Andrew Blauvelt
- Content type: Systematic Review
- Open Access
- Published: 26 July 2022
- Pages: 625 - 637
-
Pharmacists’ Perspectives of Biosimilars: A Systematic Review
Authors (first, second and last of 4)
- Noraisyah Mohd Sani
- Zoriah Aziz
- Adeeba Kamarulzaman
- Content type: Systematic Review
- Published: 01 July 2022
- Pages: 489 - 508
-
Interchangeability for Biologics is a Legal Distinction in the USA, Not a Clinical One
Authors (first, second and last of 9)
- Joseph P. Park
- Byoungin Jung
- Gillian R. Woollett
- Content type: Current Opinion
- Open Access
- Published: 13 June 2022
- Pages: 431 - 436
-
Regulatory Evaluation of Biosimilars: Refinement of Principles Based on the Scientific Evidence and Clinical Experience
Authors (first, second and last of 6)
- Pekka Kurki
- Hye-Na Kang
- Elena Wolff-Holz
- Content type: Review Article
- Open Access
- Published: 21 May 2022
- Pages: 359 - 371
-
Patients Retransitioning from Biosimilar TNFα Inhibitor to the Corresponding Originator After Initial Transitioning to the Biosimilar: A Systematic Review
Authors (first, second and last of 4)
- Rosanne W. Meijboom
- Helga Gardarsdottir
- Thijs J. Giezen
- Content type: Systematic Review
- Open Access
- Published: 06 December 2021
- Pages: 27 - 39
-
Switching from Biologic to Biosimilar Products: Insight from an Integrated Health Care System
Authors (first, second and last of 6)
- Bharati Bhardwaja
- Shilpa Klocke
- Kari L. Olson
- Content type: Leading Article
- Published: 24 November 2021
- Pages: 1 - 11
-
Is There Any Research Evidence Beyond Surveys and Opinion Polls on Automatic Substitution of Biological Medicines? A Systematic Review
Authors (first, second and last of 7)
- Hanna M. Tolonen
- Jenni Falck
- Marja Airaksinen
- Content type: Systematic Review
- Open Access
- Published: 16 August 2021
- Pages: 547 - 561
-
Comparability of Biologics: Global Principles, Evidentiary Consistency and Unrealized Reliance
Authors
- Christopher J. Webster
- Kelly L. George
- Gillian R. Woollett
- Content type: Current Opinion
- Open Access
- Published: 18 June 2021
- Pages: 379 - 387
-
Interchangeability of Biosimilars: What Level of Clinical Evidence is Needed to Support the Interchangeability Designation in the United States?
Authors (first, second and last of 5)
- Daniel F. Alvarez
- Gertjan Wolbink
- Jonathan Kay
- Content type: Review Article
- Open Access
- Published: 29 September 2020
- Pages: 723 - 732
-
PF-06410293: An Adalimumab Biosimilar
Authors
- Arnold Lee
- Matt Shirley
- Content type: Adis Biosimilar Brief
- Published: 19 September 2020
- Pages: 695 - 698
-
The Importance of Countering Biosimilar Disparagement and Misinformation
Authors
- Hillel P. Cohen
- Dorothy McCabe
- Content type: Current Opinion
- Open Access
- Published: 20 July 2020
- Pages: 407 - 414
-
Update on Biosimilar Insulins: A US Perspective
Authors
- Rong M. Zhang
- Ritika Puri
- Janet B. McGill
- Content type: Review Article
- Published: 17 July 2020
- Pages: 505 - 512
-
The Path Towards a Tailored Clinical Biosimilar Development
Authors (first, second and last of 9)
- Martin Schiestl
- Gopinath Ranganna
- Julie Maréchal-Jamil
- Content type: Review Article
- Open Access
- Published: 07 April 2020
- Pages: 297 - 306
-
MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
Authors
- Sheridan M. Hoy
- Content type: Adis Drug Evaluation
- Open Access
- Published: 25 March 2020
- Pages: 245 - 251
-
Identifying Key Benefits in European Off-Patent Biologics and Biosimilar Markets: It is Not Only About Price!
Authors (first, second and last of 4)
- Binita Dutta
- Isabelle Huys
- Steven Simoens
- Content type: Review Article
- Open Access
- Published: 02 December 2019
- Pages: 159 - 170
-
Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents
Authors (first, second and last of 6)
- Vibeke Strand
- Joao Gonçalves
- John D. Isaacs
- Content type: Review Article
- Open Access
- Published: 13 November 2019
- Pages: 27 - 37
-
Delivering on the Promise of Biosimilars
Authors
- Arnold G. Vulto
- Content type: Commentary
- Published: 12 October 2019
- Pages: 599 - 602
-
Evolution of the EU Biosimilar Framework: Past and Future
Authors (first, second and last of 4)
- Elena Wolff-Holz
- Klara Tiitso
- Martina Weise
- Content type: Review Article
- Open Access
- Published: 20 September 2019
- Pages: 621 - 634
-
Comparative Efficacy and Safety of Biosimilar Rituximab and Originator Rituximab in Rheumatoid Arthritis and Non-Hodgkin’s Lymphoma: A Systematic Review and Meta-analysis
Authors
- Soohyun Lee
- Heeyoung Lee
- EunYoung Kim
- Content type: Systematic Review
- Published: 24 August 2019
- Pages: 469 - 483
-
Extrapolation in Practice: Lessons from 10 Years with Biosimilar Filgrastim
Authors (first, second and last of 5)
- Pere Gascon
- Andriy Krendyukov
- Matti Aapro
- Content type: Review Article
- Open Access
- Published: 22 August 2019
- Pages: 635 - 645
-
An Efficient Development Paradigm for Biosimilars
Authors
- Christopher J. Webster
- Anny C. Wong
- Gillian R. Woollett
- Content type: Current Opinion
- Open Access
- Published: 06 August 2019
- Pages: 603 - 611
-
Challenges in Post-marketing Studies of Biological Drugs in the Era of Biosimilars: A Report of the International Society for Pharmacoepidemiology 2019 Mid-Year Meeting in Rome, Italy
Authors (first, second and last of 4)
- Ylenia Ingrasciotta
- Janet Sultana
- Gianluca Trifirò
- Content type: MEETING REPORT
- Published: 16 July 2019
- Pages: 345 - 352
-
Biosimilars: A Value Proposition
Authors
- Fernando de Mora
- Content type: Current Opinion
- Published: 07 June 2019
- Pages: 353 - 356
-
Efficacy and Safety of Anti-cancer Biosimilars Compared to Reference Biologics in Oncology: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Authors (first, second and last of 11)
- Jichun Yang
- Shuqing Yu
- Feng Sun
- Content type: Systematic Review
- Published: 07 June 2019
- Pages: 357 - 371
-
Efficacy and Safety of Supportive Care Biosimilars Among Cancer Patients: A Systematic Review and Meta-Analysis
Authors (first, second and last of 11)
- Jichun Yang
- Shuqing Yu
- Feng Sun
- Content type: Systematic Review
- Published: 03 June 2019
- Pages: 373 - 389
-
Adalimumab Biosimilars in Europe: An Overview of the Clinical Evidence
Authors (first, second and last of 4)
- Salvatore Bellinvia
- J. R. Fraser Cummings
- Christopher J. Edwards
- Content type: Leading Article
- Published: 20 May 2019
- Pages: 241 - 253
-
LA-EP2006: A Pegfilgrastim Biosimilar
Authors
- Sheridan M. Hoy
- Content type: Adis Biosimilar Brief
- Published: 18 March 2019
- Pages: 229 - 232
-
FKB327: An Adalimumab Biosimilar
Authors
- Zaina T. Al-Salama
- Content type: Adis Biosimilar Brief
- Published: 02 February 2019
- Pages: 113 - 116
-
Pegfilgrastim-jmdb/MYL-1401H: A Pegfilgrastim Biosimilar
Authors
- Sheridan M. Hoy
- Content type: Adis Biosimilar Brief
- Published: 30 January 2019
- Pages: 117 - 120